Fundz

Artax Biopharma, Inc. reported raising $2.16 Million in an initial SEC Form D filing, from an offering of $3 Million

PRIVATEFeb 26, 2021$2.2M of $3M raised

Amount Raised

$2.16 Million

$2.16 Million sold, per SEC Form D (first sale Feb 26, 2021)

Round Type

Seed

CambridgeBiotechnology

Quick answer

Artax Biopharma raised $2.16 Million in a Seed round, dated February 26, 2021. Artax Biopharma is based in Cambridge, Massachusetts, United States.

How much did Artax Biopharma raise?
Artax Biopharma raised $2.16 Million in a Seed round on February 26, 2021.
What does Artax Biopharma do?
Artax Biopharma is a development-stage biopharmaceutical company dedicated to the development of new therapies for autoimmune and inflammatory diseases.
Where is Artax Biopharma based and how big is it?
Artax Biopharma is based in Cambridge, Massachusetts, United States. Fundz records about 13 employees.
Who are the decision-makers at Artax Biopharma?
Fundz holds 1 contact at Artax Biopharma, including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Artax Biopharma that raised within 45 days of this round, from Fundz verified event records.

  • Ocean Biomedical raised $1M (Seed) on April 12, 2021.
  • Laxmi Therapeutic Devices raised $13M on April 12, 2021.
  • ExpressCells, Inc. raised $591K (Seed) on April 9, 2021.
  • Arcellx, Inc raised $115M on April 9, 2021.
  • selectIon raised $5.1M on April 8, 2021.
  • Revel Pharmaceuticals Inc. raised $800K (Seed) on April 8, 2021.

Who to call at Artax Biopharma, and when

A new round usually means Artax Biopharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Artax Biopharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Artax Biopharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Artax Biopharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Artax Biopharma

Location

1 BROADWAY

Cambridge, Massachusetts, United States

About

Artax Biopharma is a development-stage biopharmaceutical company dedicated to the development of new therapies for autoimmune and inflammatory diseases. Artax Biopharma is developing the next generation of drugs targeting the interaction between TCR and Nck, which is responsible for T-cell activation. Specific control over T-cells through TCR, provides the compounds with the potential to become first-in-class immunomodulators for the treatment of a wide range of autoimmune and inflammatory diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Artax Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAndre H., Director hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Artax Biopharma's next move

See what Strategic adds

Artax Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.